Summary
iTeos Therapeutics S.A. manufactures medial devices. The Company focused on the development of immunomodulators for the treatment of lung, pancreatic, and liver cancers. iTeos Therapeutics operates in Belgium.
Deals Overview
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
Senior Management
Michel Detheux
President and CEO
David Hallal
Chairman